In terms of exosome detection, Lei et al. [7] developed an assay to quantify tumor-associated miRNAs by labeling tumor-derived exosomes with allosteric EpCAM and CD63 aptamers, which serve as input units for an orthogonal identity barcode to initiate the miRNA detection process via targeted vesicle fusion. The gene discussed is CD63; the disease is neoplasm.